SHAR-004_final_logo_working_file_update

First Page		Document Content
Date: 2015-04-22 16:04:15 Tumor markers Tumor suppressor genes Medical genetics BRCA mutation Mutation BRCA2 BRCA1 Ovarian cancer In the Family Medicine Oncology Breast cancer		SHAR-004_final_logo_working_file_update Add to Reading List Source URL: www.penncancer.org Download Document from Source Website File Size: 558,14 KB Share Document on Facebook

	Outlaw Human Gene Patents Because Human Genes Belong to Human Beings NOT Corporations. The US Supreme Court is currently considering the question DocID: 1qIXp - View Document
	ENGLISH SUMMARY Ovarian cancer is the most lethal gynaecologic cancer. Today, there is no population-based screening tool in ovarian cancer and as the disease typically has a vague clinical presentation; most women are d DocID: 1quQa - View Document
	CNE Objectives and Evaluation Form appear on pageSERIES Deciphering the Diagnostics of Breast Cancer DocID: 1oQ5n - View Document
	S P E C I A L A D V E R T I S I N G eauty DocID: 19JOV - View Document
	ARIEL2: A phase 2 study to prospectively identify ovarian cancer patients likely to respond to rucaparib Elizabeth Swisher,1 James Brenton,2 Scott Kaufmann,3 Amit Oza,4 Robert L. Coleman,5 David O’Malley,6 Gottfried Ko DocID: 19bpI - View Document